High Alert

This common vitamin could help fight one of the deadliest brain cancers

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: ScienceDaily

What happened

High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months.

Key facts

  • High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months.
  • Reported by ScienceDaily and published Sun, 04 Oct 2026 10:09:00 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by ScienceDaily. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at ScienceDaily

Related WorldPing coverage

ScienceDaily
WorldPing
ScienceDaily

Your gut bacteria may reveal how fast your brain is aging

A UCLA study links faster brain aging to specific gut bacteria and chemical byproducts, with older-looking brains also associated with poorer memory, focus, and mood.

Brief by WorldPing · Original reporting by ScienceDaily